Managers / Q1 2023 · view latest →
Cohen & Co Financial Management, LLC
CIK 0001778536 · 3 COLUMBUS CIRCLE, 24TH FLOOR, NEW YORK, NY, 10019 · 646-965-8215
Summary
Cohen & Co Financial Management, LLC reported $34M in U.S.-listed holdings across 9 positions for Q1 2023.
The portfolio is heavily concentrated: Lanzatech Global alone accounts for 36.6% of reported value.
Compared with Q4 2022, the fund opened 3 new positions and exited 2.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Other · 62.7% · $21M
- Common Stock · 34.8% · $12M
- Equity WRT · 2.5% · $844,200
Quarter-over-Quarter Changes full breakdown →
vs Q4 2022 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| LANZATECH GLOBAL INC | NEW | +2.99M | 2.99M | +$12M | $12M |
| OCEAOCEAN BIOMEDICAL INC | NEW | +1.52M | 1.52M | +$10M | $10M |
| LANZATECH GLOBAL INC | NEW | +2.01M | 2.01M | +$844,200 | $844,200 |
| EF HUTTON ACQUISITION CORP I | SOLD OUT | −249.9K | 0 | −$3,999 | $0 |
| KNIGHTSWAN ACQUISITION CORP | SOLD OUT | −22.3K | 0 | −$1,004 | $0 |
| SATIXFY COMMUNICATIONS LTD | TRIMMED | −3.31M | 2.84M | −$42M | $2M |
| SFRTAPPRECIATE HOLDINGS INC | HELD | +0 | 3.07M | −$1M | $2M |
| SHF HOLDINGS INC | HELD | +0 | 971.2K | −$1M | $495,314 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2023
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | LANZATECH GLOBAL INC | COM · *W EXP 01/01/202 | 36.61% | $12M | 5.00M |
| 2 | OCEAOCEAN BIOMEDICAL INChistory → | COM | 29.66% | $10M | 1.52M |
| 3 | GOLDEN FALCON ACQUISITION CO | CL A | 14.90% | $5M | 500.0K |
| 4 | SATIXFY COMMUNICATIONS LTD | ORD SHS | 5.64% | $2M | 2.84M |
| 5 | SFRTAPPRECIATE HOLDINGS INChistory → | CLASS A COM | 5.14% | $2M | 3.07M |
| 6 | SEASTAR MEDICAL HOLDING CORP | COMMON STOCK | 3.41% | $1M | 623.4K |
| 7 | RUBICON TECHNOLOGIES INC | CL A COM | 3.17% | $1M | 1.64M |
| 8 | SHF HOLDINGS INC | CLASS A COM | 1.46% | $495,314 | 971.2K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q3 2023 | $18M | 8 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $24M | 7 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $34M | 9 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $58M | 8 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $58M | 28 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $101M | 71 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $14M | 79 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $151M | 109 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $238M | 152 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $157M | 64 | Jul 28, 2021 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.